MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway

BACKGROUND: Chemoresistance influences the therapeutic effect of cisplatin and remains a major obstacle to its clinical use. MicroRNAs are associated with drug resistance of various tumors. However, the association between microRNAs and cisplatin in lung cancer remains largely unclear. METHODS: Micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Zu, Lingling, Wu, Heng, Zhang, Fang, Fan, Yaguang, Pan, Hongli, Du, Xinxin, Guo, Fengjie, Zhou, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807278/
https://www.ncbi.nlm.nih.gov/pubmed/34953057
http://dx.doi.org/10.1111/1759-7714.14278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807278/
https://www.ncbi.nlm.nih.gov/pubmed/34953057
http://dx.doi.org/10.1111/1759-7714.14278

Ejemplares similares